HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

drotrecogin alfa activated (Xigris)

recombiant human activated protein C
Also Known As:
Xigris; Lilly brand of drotrecogin alfa activated; rhAPC
Networked: 399 relevant articles (63 outcomes, 128 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Williams, Mark D: 21 articles (11/2012 - 04/2003)
2. Vincent, Jean-Louis: 19 articles (07/2011 - 08/2002)
3. Macias, William L: 13 articles (02/2013 - 10/2002)
4. Bernard, Gordon R: 13 articles (06/2006 - 01/2003)
5. Nelson, David R: 12 articles (05/2011 - 07/2003)
6. Levy, Howard: 12 articles (09/2007 - 01/2003)
7. Dhainaut, Jean-François: 11 articles (05/2012 - 12/2002)
8. Artigas, Antonio: 10 articles (01/2015 - 03/2003)
9. Yan, S Betty: 10 articles (06/2010 - 07/2003)
10. Abraham, Edward: 10 articles (01/2009 - 12/2002)

Related Diseases

1. Sepsis (Septicemia)
2. Septic Shock (Toxic Shock Syndrome)
3. Hemorrhage
4. Inflammation
5. Shock

Related Drugs and Biologics

1. Protein C
2. drotrecogin alfa activated (Xigris)
3. Heparin (Liquaemin)
4. Antithrombin III
5. Adrenal Cortex Hormones (Corticosteroids)
6. Tifacogin
7. lipoprotein-associated coagulation inhibitor (TFPI)
8. fibrin fragment D (D-dimer)
9. rho-Associated Kinases
10. Interleukin-6 (Interleukin 6)

Related Therapies and Procedures

1. Intensive Care (Surgical Intensive Care)
2. Transplants (Transplant)
3. Resuscitation
4. Stents
5. Liver Transplantation